These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29045288)

  • 21. A New Perspective for Chinese Medicine Intervention for Coronary Artery Disease: Targeting Inflammation.
    Li SM; Li JG; Xu H
    Chin J Integr Med; 2019 Jan; 25(1):3-8. PubMed ID: 30132247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colchicine for the Prevention of Cardiovascular Disease: Potential Global Implementation.
    Zhang RS; Weber BN; Araiza-Garaygordobil D; Garshick MS
    Curr Cardiol Rep; 2024 May; 26(5):423-434. PubMed ID: 38573553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colchicine for the treatment of coronary artery disease.
    Aimo A; Pascual-Figal DA; Barison A; Cediel G; Vicente ÁH; Saccaro LF; Emdin M; Bayes-Genis A
    Trends Cardiovasc Med; 2021 Nov; 31(8):497-504. PubMed ID: 33096241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute coronary syndromes: Promising data for losmapimod in NSTEMI.
    Roberts A
    Nat Rev Cardiol; 2014 Aug; 11(8):436. PubMed ID: 24981141
    [No Abstract]   [Full Text] [Related]  

  • 27. The Role of Colchicine in Coronary Artery Disease.
    Butt AK; Cave B; Maturana M; Towers WF; Khouzam RN
    Curr Probl Cardiol; 2021 Mar; 46(3):100690. PubMed ID: 32994053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory strategies in coronary atherosclerosis.
    Burton PB; Daniel TO
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1725-8. PubMed ID: 12528306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Antiatherosclerotic Therapies.
    Libby P; Everett BM
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):538-545. PubMed ID: 30816799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory Therapeutics and Coronary Artery Disease.
    Eghtedari B; Roy SK; Budoff MJ
    Cardiol Rev; 2023 Mar-Apr 01; 31(2):80-86. PubMed ID: 35471811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of secreted and lipoprotein-associated phospholipase A2 in cardiovascular risk].
    Ferri N; Corsini A
    G Ital Cardiol (Rome); 2014 Dec; 15(12):664-9. PubMed ID: 25533115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophils.
    Marks-Konczalik J; Costa M; Robertson J; McKie E; Yang S; Pascoe S
    Respir Med; 2015 Jul; 109(7):860-9. PubMed ID: 26033641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Losmapimod: a novel drug against cardiovascular diseases?].
    Dewenter M; Vettel C; El-Armouche A
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):39-42. PubMed ID: 23250695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD.
    Müller KA; Chatterjee M; Rath D; Geisler T
    Thromb Haemost; 2015 Aug; 114(3):498-518. PubMed ID: 26224127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit?
    Maiorino MI; Bellastella G; Giugliano D; Esposito K
    Endocrine; 2017 Feb; 55(2):360-365. PubMed ID: 27230767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel oral anticoagulants in acute coronary syndrome.
    Costopoulos C; Niespialowska-Steuden M; Kukreja N; Gorog DA
    Int J Cardiol; 2013 Sep; 167(6):2449-55. PubMed ID: 22989603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
    Giannopoulos G; Angelidis C; Papoutsidakis N; Panagopoulou V; Cleman MW; Lekakis J; Deftereos S
    Curr Med Chem; 2015; 22(36):4177-88. PubMed ID: 26467282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.
    Packard KA; Campbell JA; Knezevich JT; Davis EM
    Pharmacotherapy; 2012 Mar; 32(3):244-73. PubMed ID: 22392457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varespladib methyl, an oral phospholipase A2 inhibitor for the potential treatment of coronary artery disease.
    Karakas M; Koenig W
    IDrugs; 2009 Sep; 12(9):585-92. PubMed ID: 19697278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.